These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1395454)

  • 21. The treatment of irritable bowel syndrome. Two doses of mebeverine compared.
    Prout BJ
    Practitioner; 1983 Oct; 227(1384):1607-8. PubMed ID: 6356119
    [No Abstract]   [Full Text] [Related]  

  • 22. Otilonium bromide: a selective spasmolytic for the gastrointestinal tract.
    Evangelista S
    J Int Med Res; 1999; 27(5):207-22. PubMed ID: 10689627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of mebeverine with high-fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group study.
    Chapman ND; Grillage MG; Mazumder R; Atkinson SN
    Br J Clin Pract; 1990 Nov; 44(11):461-6. PubMed ID: 2177997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sulpiride treatment of irritable colon syndrome].
    Komarov FI; Rapoport SI; Ivanov SV; Kharaian LV; Kolesnikov DB; Kurikov AV
    Klin Med (Mosk); 2000; 78(7):22-6. PubMed ID: 10979637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Controlled clinical study of the action of mebeverine hydrochloride in the treatment of irritable colon].
    Secco GB; Di Somma C; Arnulfo G; Ricci C
    Minerva Med; 1983 Mar; 74(13):699-702. PubMed ID: 6339996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended analysis of a double-blind, placebo-controlled, 15-week study with otilonium bromide in irritable bowel syndrome.
    Glende M; Morselli-Labate AM; Battaglia G; Evangelista S
    Eur J Gastroenterol Hepatol; 2002 Dec; 14(12):1331-8. PubMed ID: 12468954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of irritable bowel syndrome with prifinium bromide.
    Sasaki D; Suzuki A; Yoshida Y; Okamoto K; Ohmi T; Takahashi S; Yoshida S; Fukushi K; Higuchi K
    Clin Ther; 1985; 7(2):190-8. PubMed ID: 2859117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndrome.
    Centonze V; Imbimbo BP; Campanozzi F; Attolini E; Daniotti S; Albano O
    Am J Gastroenterol; 1988 Nov; 83(11):1262-6. PubMed ID: 3055943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome.
    Kountouras J; Chatzopoulos D; Zavos C; Boura P; Venizelos J; Kalis A
    Hepatogastroenterology; 2002; 49(43):193-7. PubMed ID: 11941952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different therapeutic regimens in irritable bowel syndrome.
    Nigam P; Kapoor KK; Rastog CK; Kumar A; Gupta AK
    J Assoc Physicians India; 1984 Dec; 32(12):1041-4. PubMed ID: 6526796
    [No Abstract]   [Full Text] [Related]  

  • 31. [The irritable colon syndrome. New therapeutic possibilities in the treatment of a frequent syndrome].
    Eisenburg J; Kruis W; Schüssler P; Weinzierl M
    Fortschr Med; 1978 Nov; 96(41):2064-70. PubMed ID: 700592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of two different formulations of mebeverine hydrochloride in irritable bowel syndrome.
    Gilbody JS; Fletcher CP; Hughes IW; Kidman SP
    Int J Clin Pract; 2000 Sep; 54(7):461-4. PubMed ID: 11070572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide.
    Narducci F; Bassotti G; Granata MT; Pelli MA; Gaburri M; Palumbo R; Morelli A
    Dig Dis Sci; 1986 Mar; 31(3):241-6. PubMed ID: 3948628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Open-label, dose-ranging pilot study of 4 weeks of low-dose therapy with sodium phosphate tablets in chronically constipated adults.
    Medoff J; Katz S; Malik P; Pambianco D; Pruitt R; Poulos J; Rank J; Rose M
    Clin Ther; 2004 Sep; 26(9):1479-91. PubMed ID: 15531010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and instrumental evaluation by multiple colonic manometry of tiropramide, trimebutine and octylonium bromide in the irritable colon: I. Administration by single i.v].
    Galeone M; Stock F; Moise G; Cacioli D; Benazzi E; Riva A
    Pharmatherapeutica; 1986; 4(7):445-56. PubMed ID: 3960945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Japanese clinical statistical data of patients with irritable bowel syndrome].
    Inoue M
    Nihon Rinsho; 1992 Nov; 50 Suppl():517-29. PubMed ID: 1364250
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacological studies on otilonium bromide.
    Giachetti A
    Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):56-9. PubMed ID: 1661629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pinaverine bromide in the treatment of irritable colon].
    Di Simone A; Plaitano G; Politi C
    Minerva Dietol Gastroenterol; 1981; 27(4):579-84. PubMed ID: 7038543
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of tricyclics and benzodiazepine compounds in the treatment of irritable gut syndrome and peptic ulcer disease.
    Shrivastava RK; Siegel H
    Psychopharmacol Bull; 1984; 20(4):616-21. PubMed ID: 6149597
    [No Abstract]   [Full Text] [Related]  

  • 40. [Motility of the sigmoid in irritable bowel syndrome and colonic diverticulosis].
    Ritsema GH; Thijn CJ; Smout AJ
    Ned Tijdschr Geneeskd; 1990 Jul; 134(29):1398-401. PubMed ID: 2374631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.